Stay updated on Avelumab Combo Regimens in R/R DLBCL Clinical Trial
Sign up to get notified when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.

Latest updates to the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the revision tag to v3.3.1. The previous PubMed publication note and revision tag v3.2.0 were removed/updated to reflect the new wording.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice about a lapse in government funding and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record now shows termination of the trial with closure of arms due to futility and enrollment challenges, citing evolving treatment landscape as the rationale.SummaryDifference0.3%

- Check63 days agoChange DetectedCore content updated to reflect government funding status and a new version (v3.2.0) with added lymphoma resource; previous version (v3.1.0) removed.SummaryDifference2%

- Check71 days agoChange DetectedPage update: version bumped to v3.1.0 with removal of the 'Diffuse large B-cell lymphoma' topic from the resources.SummaryDifference0.3%

Stay in the know with updates to Avelumab Combo Regimens in R/R DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.